Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease.
Suur BE, Chemaly M, Lindquist Liljeqvist M, Djordjevic D, Stenemo M, Bergman O, Karlöf E, Lengquist M, Odeberg J, Hurt-Camejo E, Eriksson P, Ketelhuth DFJ, Roy J, Hedin U, Nyberg M, Matic L. Suur BE, et al. Among authors: hurt camejo e. Front Pharmacol. 2022 Sep 15;13:988561. doi: 10.3389/fphar.2022.988561. eCollection 2022. Front Pharmacol. 2022. PMID: 36188622 Free PMC article.
Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis.
Aldi S, Matic LP, Hamm G, van Keulen D, Tempel D, Holmstrøm K, Szwajda A, Nielsen BS, Emilsson V, Ait-Belkacem R, Lengquist M, Paulsson-Berne G, Eriksson P, Lindeman JHN, Gool AJ, Stauber J, Hedin U, Hurt-Camejo E. Aldi S, et al. Mol Ther Methods Clin Dev. 2018 Jun 27;10:17-28. doi: 10.1016/j.omtm.2018.05.003. eCollection 2018 Sep 21. Mol Ther Methods Clin Dev. 2018. PMID: 30003117 Free PMC article.
3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr-/- mice.
Berg M, Polyzos KA, Agardh H, Baumgartner R, Forteza MJ, Kareinen I, Gisterå A, Bottcher G, Hurt-Camejo E, Hansson GK, Ketelhuth DFJ. Berg M, et al. Among authors: hurt camejo e. Cardiovasc Res. 2020 Oct 1;116(12):1948-1957. doi: 10.1093/cvr/cvz258. Cardiovasc Res. 2020. PMID: 31589306 Free PMC article.
Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers.
Pieterman EJ, Princen HMG, Jarke A, Nilsson R, Cavallin A, Bergenholm L, Henricsson M, Gopaul VS, Agrawal R, Nissen SE, Hurt-Camejo E. Pieterman EJ, et al. Among authors: hurt camejo e. Front Pharmacol. 2021 Aug 16;12:681455. doi: 10.3389/fphar.2021.681455. eCollection 2021. Front Pharmacol. 2021. PMID: 34483899 Free PMC article.
Does statins promote vascular calcification in chronic kidney disease?
Chen Z, Qureshi AR, Parini P, Hurt-Camejo E, Ripsweden J, Brismar TB, Barany P, Jaminon AM, Schurgers LJ, Heimbürger O, Lindholm B, Stenvinkel P. Chen Z, et al. Eur J Clin Invest. 2017 Feb;47(2):137-148. doi: 10.1111/eci.12718. Eur J Clin Invest. 2017. PMID: 28036114
Phospholipase A(2) in vascular disease.
Hurt-Camejo E, Camejo G, Peilot H, Oörni K, Kovanen P. Hurt-Camejo E, et al. Circ Res. 2001 Aug 17;89(4):298-304. doi: 10.1161/hh1601.095598. Circ Res. 2001. PMID: 11509445 Review.
Group IIA Secretory Phospholipase A2, Vascular Inflammation, and Incident Cardiovascular Disease.
Akinkuolie AO, Lawler PR, Chu AY, Caulfield M, Mu J, Ding B, Nyberg F, Glynn RJ, Ridker PM, Hurt-Camejo E, Chasman DI, Mora S. Akinkuolie AO, et al. Among authors: hurt camejo e. Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1182-1190. doi: 10.1161/ATVBAHA.118.311894. Arterioscler Thromb Vasc Biol. 2019. PMID: 31070471 Free PMC article. Clinical Trial.
88 results